Use of commercial pharmaceutical drug (Daktarin®) for retrospective/accidental/forensic thermoluminescence dosimetry

• Published in: Applied radiation and isotopes Vol. 166; p. 109364
• Main Authors: Karampiperi, Maria, Tsirliganis, Nestor C., Kazakis, Nikolaos A.
• Format: Journal Article
• Language: English
• Published: Elsevier Ltd 01.12.2020
• Subjects: Accidental dosimetry; Daktarin; Deconvolution; Dosimetry; Drugs; Pharmaceuticals; Thermoluminescence; Drugs; Deconvolution; Accidental dosimetry; Dosimetry; Thermoluminescence; Daktarin; Pharmaceuticals
• ISSN: 0969-8043; 1872-9800
• DOI: 10.1016/j.apradiso.2020.109364

Retrospective/accidental dosimetry seeks for materials that can be used as probes for the dose assessment by means of several methods when there is no dose data available (e.g. from personal dosimeters). In the same respect, researchers also seek materials appropriate for forensic purposes, which would allow to identify the prior presence of radioactive materials at buildings, sites or even vehicles. To this direction, several solid-state drugs, which are ubiquitous, have also been studied as probes for the dose estimation in emergency situations. However, due to their heat-sensitive character, measurements were possible only with OSL. The scope of the present work is to identify a heat-resistant drug (Daktarin) and conduct, for the first time, a detailed study of the thermoluminescence properties of it along with computerized curve deconvolution analysis which would shed light on the traps involved. Results indicate that the glow curve of Daktarin has at least three peaks that can be used for dosimetric purposes, since they exhibit linear dose response for doses up to 20 Gy, do not exhibit any sensitization, have high lifetime and their stability with time is good, since an appreciable signal remains unaffected even 3 months post irradiation. All the above were validated conducting dose recovery tests and successfully calculating the unknown delivered dose for various periods after the irradiation of the samples. The new findings are very supportive and point towards the efficient use of commercial pharmaceuticals as probes for retrospective/accidental/forensic dosimetry using thermoluminescence. •Daktarin@ is explored towards its use at retrospective/post-sterilization dosimetry.•TL dose response can be fitted with a linear function for doses up to 20 Gy.•The minimum detectable dose is less than 5 mGy.•A significant signal remains stored even 3 months after its irradiation.•Dose recovery tests were successfully conducted.